Department of General Practice, School of Medicine, Sorbonne University, Paris, France.
Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP), équipe PEPITES, AP-HP, Hôpital Pitié Salpêtrière, Département de Santé Publique, Centre de Pharmacoépidémiologie (Cephepi), Unité de Recherche Clinique PSL-CFX, Paris, France.
Eur J Gen Pract. 2024 Dec;30(1):2407600. doi: 10.1080/13814788.2024.2407600. Epub 2024 Oct 14.
The use of generic drugs is a way for healthcare systems to reduce costs, particularly in ambulatory care. Several studies suggest that the prescriber's speciality is associated with the use of generic drugs, and that substitutable drugs prescribed by General Practitioners (GPs) are more often generic, but this association has never been studied in France. In the French legislative context, except in rare situations, all substitutable drugs prescribed should be dispensed in generic form.
Compare the generic drugs dispensing rate among substitutable drugs dispensed in community pharmacies prescribed by French private GPs with that of other private specialists, all other specialities combined (first objective) or each other speciality taken individually (second objective).
We used a sample of an open available semi-aggregated database from the 2019 French health insurance system database. We compared with logistic regression models GPs to all other specialities combined, then GPs to the 19 other specialties taken individually, only on the substitutable drugs they prescribe in common.
In 2019, 53.4% of the drugs prescribed by French private ambulatory physicians were substitutable drugs, and 81.5% of them were dispensed in generic form. After adjustment, the generic dispensing rate for substitutable drugs was significantly higher for GPs than for other specialties (ORa 0.74 [IC95% 0.72-0.76]). Thirteen of the nineteen other specialities taken individually, such as endocrinologists (ORa 0.64 [IC95% 0.57-0.72]) and cardiologists (ORa 0.60 [0.56-0.63]) had significantly lower generic dispensing rates than GPs. No other speciality had a rate significantly higher than GPs.
Substitutable drugs prescribed by French private GPs are more often dispensed in generic form than those from other private ambulatory specialties. To understand this result and optimise the use of generic drugs in outpatient settings, we need to study the different stages of drug use, from prescription by the physician to dispensing by the pharmacist and acceptance by the patient.
在门诊护理中,使用仿制药是医疗保健系统降低成本的一种方式。多项研究表明,医生的专业与仿制药的使用有关,而且全科医生(GP)开的可替代药物更常是仿制药,但这种关联从未在法国进行过研究。在法国立法背景下,除了在极少数情况下,所有可替代药物都应以仿制药的形式配药。
比较法国私人全科医生开具的社区药房中可替代药物的仿制药配药率与其他私人专科医生(所有其他专科医生合并)或单独的每个其他专科医生的仿制药配药率。
我们使用了来自 2019 年法国健康保险系统数据库的一个开放可用的半聚合数据库的样本。我们使用逻辑回归模型比较了全科医生与所有其他专科医生合并,然后与每个其他专科医生进行了比较,仅比较他们共同开的可替代药物。
2019 年,法国私人门诊医生开具的药物中 53.4%为可替代药物,其中 81.5%以仿制药形式配药。调整后,可替代药物的仿制药配药率在全科医生中显著高于其他专科医生(ORa 0.74 [95%CI 0.72-0.76])。19 个其他专科医生中的 13 个,如内分泌科医生(ORa 0.64 [95%CI 0.57-0.72])和心脏病专家(ORa 0.60 [0.56-0.63])的仿制药配药率显著低于全科医生。没有其他专科医生的配药率显著高于全科医生。
法国私人全科医生开具的可替代药物更常以仿制药的形式配药,而不是其他私人门诊专科医生开具的可替代药物。为了理解这一结果并优化门诊环境中仿制药的使用,我们需要研究从医生处方到药剂师配药和患者接受的药物使用的不同阶段。